| P50 | author | Lorenzo Montanaro | Q70802887 |
| P2093 | author name string | Davide Treré | |
| | Massimo Derenzini | |
| P2860 | cites work | A telomerase component is defective in the human disease dyskeratosis congenita | Q22010917 |
| | The Treacher Collins syndrome (TCOF1) gene product is involved in ribosomal DNA gene transcription by interacting with upstream binding factor | Q24299223 |
| | Mechanism of repression of RNA polymerase I transcription by the retinoblastoma protein | Q40022814 |
| | Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer. | Q40255839 |
| | Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita | Q40280985 |
| | Hepatitis C virus core protein stimulates hepatocyte growth: correlation with upregulation of wnt-1 expression | Q40432971 |
| | c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription. | Q40456137 |
| | The AgNOR proteins: qualitative and quantitative changes during the cell cycle | Q40913847 |
| | The hepatitis B virus X-gene product trans-activates both RNA polymerase II and III promoters | Q41202761 |
| | Activity of RNA polymerase I transcription factor UBF blocked by Rb gene product | Q41361034 |
| | Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: matched case-control study, pathological analysis, and pathogenetic hypothesis | Q41661374 |
| | Activation of RNA polymerase I transcription by hepatitis C virus core protein | Q42982560 |
| | Enhanced telomere shortening in transformed lymphoblasts from patients with X linked dyskeratosis | Q43011016 |
| | HCV core expression in hepatocytes protects against autoimmune liver injury and promotes liver regeneration in mice | Q43031843 |
| | Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification | Q44274699 |
| | The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis | Q44851701 |
| | Initiation of mRNA translation in oncogenesis: the role of eIF4E. | Q45113363 |
| | Nucleolar size indicates the rapidity of cell proliferation in cancer tissues | Q47236518 |
| | Nucleolar size and activity are related to pRb and p53 status in human breast cancer. | Q47400382 |
| | Relationship between interphase AgNOR distribution and nucleolar size in cancer cells | Q47403743 |
| | Extraribosomal functions of ribosomal proteins. | Q52305448 |
| | Targeted disruption of Dkc1, the gene mutated in X-linked dyskeratosis congenita, causes embryonic lethality in mice. | Q52547997 |
| | A mammalian mitochondrial RNA processing activity contains nucleus-encoded RNA. | Q54410062 |
| | Nucleolar hypertrophy correlates with hepatocellular carcinoma development in cirrhosis due to HBV infection | Q57004663 |
| | Repression of RNA polymerase III transcription by the retinoblastoma protein | Q58450660 |
| | Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells | Q59054505 |
| | Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level | Q68963399 |
| | Telomeres, the nucleolus and aging | Q74701358 |
| | An encore for ribosome biogenesis in the control of cell proliferation | Q33915837 |
| | Mutations in SBDS are associated with Shwachman-Diamond syndrome | Q33963285 |
| | Overlapping functions of the pRb family in the regulation of rRNA synthesis | Q33969313 |
| | The Pezcoller lecture: cancer cell cycles revisited | Q33987290 |
| | Human tumor suppressor p14ARF negatively regulates rRNA transcription and inhibits UBF1 transcription factor phosphorylation. | Q33998894 |
| | The Rb/E2F pathway: expanding roles and emerging paradigms | Q34052659 |
| | Dyskeratosis congenita in all its forms | Q34071682 |
| | Life on a planet of its own: regulation of RNA polymerase I transcription in the nucleolus | Q34214625 |
| | Deregulation of cell growth and malignant transformation. | Q34443028 |
| | Nucleolar adaptation in human cancer | Q34452742 |
| | Consequences of mutations in the non-coding RMRP RNA in cartilage-hair hypoplasia | Q34463484 |
| | Phylogeny, sequence conservation, and functional complementation of the SBDS protein family | Q34501225 |
| | The nucleolus--a gateway to viral infection? | Q34732586 |
| | The RB and p53 pathways in cancer | Q34804764 |
| | Conventional and nonconventional roles of the nucleolus | Q34813102 |
| | The RNA of RNase MRP is required for normal processing of ribosomal RNA. | Q34991585 |
| | The prognostic value of the AgNOR parameter in human breast cancer depends on the pRb and p53 status | Q35587776 |
| | Nucleolar function and size in cancer cells | Q35765408 |
| | Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia | Q35798342 |
| | Preneoplastic lesions in human hepatocarcinogenesis | Q36033377 |
| | Cellular stress and nucleolar function | Q36276746 |
| | The flexible evolutionary anchorage-dependent Pardee's restriction point of mammalian cells: how its deregulation may lead to cancer | Q36283957 |
| | Molecular basis of hepatitis C virus-associated hepatocarcinogenesis: lessons from animal model studies | Q36290065 |
| | HBV induced carcinogenesis | Q36388400 |
| | Do truncated cyclins contribute to aberrant cyclin expression in cancer? | Q36427775 |
| | Structure and function of the nucleolus in the spotlight | Q36474418 |
| | The Myc oncoprotein as a therapeutic target for human cancer | Q36578165 |
| | Interphase Nucleolar Organizer Regions in Cancer Cells | Q36670329 |
| | Mutations in the Drosophila gene encoding ribosomal protein S6 cause tissue overgrowth | Q36679294 |
| | Is high AgNOR quantity in hepatocytes associated with increased risk of hepatocellular carcinoma in chronic liver disease? | Q37239027 |
| | Drosophila homolog of the human S6 ribosomal protein is required for tumor suppression in the hematopoietic system | Q37317692 |
| | A role for c-Myc in the regulation of ribosomal RNA processing | Q37368698 |
| | Structural organization of the nucleolus in mammalian cells | Q38161228 |
| | Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia | Q24337910 |
| | Phosphorylation by G1-specific cdk-cyclin complexes activates the nucleolar transcription factor UBF. | Q24534046 |
| | Immunopurified small nucleolar ribonucleoprotein particles pseudouridylate rRNA independently of their association with phosphorylated Nopp140. | Q24540218 |
| | Repression of RNA polymerase I transcription by the tumor suppressor p53 | Q24552501 |
| | Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23 | Q24629309 |
| | Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita | Q24680286 |
| | Many ribosomal protein genes are cancer genes in zebrafish | Q24796901 |
| | CDK inhibitors: positive and negative regulators of G1-phase progression | Q27860983 |
| | Specific Role for Yeast Homologs of the Diamond Blackfan Anemia-associated Rps19 Protein in Ribosome Synthesis | Q27930946 |
| | The Shwachman-Bodian-Diamond syndrome protein mediates translational activation of ribosomes in yeast | Q27936929 |
| | Surfing the p53 network | Q28032484 |
| | Rb and p130 regulate RNA polymerase I transcription: Rb disrupts the interaction between UBF and SL-1 | Q28141914 |
| | The INK4a/ARF network in tumour suppression | Q28190064 |
| | Tumor suppression by Ink4a-Arf: progress and puzzles | Q28207959 |
| | c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I | Q28236082 |
| | Principles of tumor suppression | Q28240740 |
| | The Treacher Collins syndrome (TCOF1) gene product is involved in pre-rRNA methylation | Q28254083 |
| | Positional cloning of a gene involved in the pathogenesis of Treacher Collins syndrome. The Treacher Collins Syndrome Collaborative Group | Q28273395 |
| | Size control in animal development | Q28297142 |
| | The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia | Q28297163 |
| | Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6 | Q28588241 |
| | Role of nucleophosmin in embryonic development and tumorigenesis | Q28591282 |
| | Telomere shortening and tumor formation by mouse cells lacking telomerase RNA | Q29615386 |
| | Does the ribosome translate cancer? | Q29618775 |
| | p53 in health and disease | Q29619939 |
| | Nucleolar Arf sequesters Mdm2 and activates p53 | Q29620244 |
| | Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap | Q29620550 |
| | Ribosomal proteins in cell proliferation and apoptosis | Q30586634 |
| | The INK4A/ARF locus and its two gene products | Q33540080 |
| | Regulation of RNA polymerase I-dependent promoters by the hepatitis B virus X protein via activated Ras and TATA-binding protein | Q33781677 |
| | The AgNORs | Q33788354 |
| | AgNOR staining and quantification | Q33788360 |
| | Regulation of the G1 phase of the mammalian cell cycle | Q33892156 |
| | Gene expression patterns in human liver cancers | Q33898932 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 301-310 | |
| P577 | publication date | 2008-06-26 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Nucleolus, ribosomes, and cancer | |
| P478 | volume | 173 | |